Radcliffe Capital Management’s American Oncology Network, Inc. Class A Common Stock AONC Stock Holding History

Radcliffe Capital Management’s Portfolio AONC Stock Details AONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-605,146	Closed	-$6.08M	–	727
2022 Q4	$6.08M	Hold	605,146	–	–	0.19%	150
2022 Q3	$5.94M	Buy	605,146 +4,129	+0.7%	+$40.6K	0.14%	211
2022 Q2	$5.88M	Buy	601,017 +44,790	+8%	+$438K	0.14%	210
2022 Q1	$5.43M	Buy	556,227 +56,227	+11%	+$546K	0.12%	197
2021 Q4	$4.86M	Hold	500,000	–	–	0.13%	205
2021 Q3	$4.85M	Hold	500,000	–	–	0.14%	177
2021 Q2	$4.87M	Buy	+500,000	New	+$4.89M	0.15%	165

Other funds holding AONC

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

SCM

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

AIMCA

Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $16.7B AUM 23.27% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

FTCM

Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return

SCM

Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return

KIM

Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return

MSU

Mizuho Securities USA New York $4.24B AUM 22.54% 1-Year Est. Return

Radcliffe Capital Management's AONC Position: Q1 2023 in Review

Radcliffe Capital Management sold out of American Oncology Network, Inc. Class A Common Stock (AONC) in Q1 2023, closing a stake of 605,146 shares — an estimated $6.08M sold.

Radcliffe Capital Management first reported a position in AONC in Q2 2021 and held it in 7 quarters. The position peaked at $6.08M in Q4 2022. 13 funds tracked by Wall St. Rank hold AONC as of Q1 2023.

Radcliffe Capital Management reported no remaining American Oncology Network, Inc. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
Radcliffe Capital Management sold 605,146 American Oncology Network, Inc. Class A Common Stock shares in Q1 2023, an estimated $6.08M.
Radcliffe Capital Management first reported a position in American Oncology Network, Inc. Class A Common Stock in Q2 2021 and held it in 7 quarters.
Radcliffe Capital Management's American Oncology Network, Inc. Class A Common Stock position peaked at $6.08M in Q4 2022.
13 funds tracked by Wall St. Rank held American Oncology Network, Inc. Class A Common Stock as of Q1 2023.

Based on Radcliffe Capital Management's 13F filing for Q1 2023, filed 15 May 2023.